Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Sesen Bio (SESN) stock

Learn how to easily invest in Sesen Bio stock.

Sesen Bio, Inc
NASDAQ: SESN - USD
BIOTECHNOLOGY
$0
-

Sesen Bio, Inc is a biotechnology business based in the US. Sesen Bio shares (SESN) are listed on the NASDAQ and all prices are listed in US Dollars. Sesen Bio employs 27 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Sesen Bio

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SESN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Sesen Bio stock price (NASDAQ: SESN)

Use our graph to track the performance of SESN stocks over time.

Sesen Bio shares at a glance

Information last updated 2021-07-24.
Latest market close$3.35
52-week range$0.91 - $4.80
50-day moving average $4.13
200-day moving average $2.92
Wall St. target price$7.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.05

Buy Sesen Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sesen Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sesen Bio price performance over time

Historical closes compared with the close of $3.35 from 2021-05-28

1 week (2021-07-15) N/A
1 month (2021-06-25) -19.66%
3 months (2021-04-26) 13.18%
6 months (2021-01-22) N/A
1 year (2020-07-22) N/A
2 years (2019-07-22) N/A
3 years (2018-07-22) N/A
5 years (2016-07-22) N/A

Sesen Bio financials

Revenue TTM $15.5 million
Gross profit TTM $-17,955,000
Return on assets TTM -11.6%
Return on equity TTM -861.97%
Profit margin 0%
Book value $0.05
Market capitalisation $668.9 million

TTM: trailing 12 months

Shorting Sesen Bio shares

There are currently 16.7 million Sesen Bio shares held short by investors – that's known as Sesen Bio's "short interest". This figure is 79.1% up from 9.3 million last month.

There are a few different ways that this level of interest in shorting Sesen Bio shares can be evaluated.

Sesen Bio's "short interest ratio" (SIR)

Sesen Bio's "short interest ratio" (SIR) is the quantity of Sesen Bio shares currently shorted divided by the average quantity of Sesen Bio shares traded daily (recently around 8.6 million). Sesen Bio's SIR currently stands at 1.95. In other words for every 100,000 Sesen Bio shares traded daily on the market, roughly 1950 shares are currently held short.

However Sesen Bio's short interest can also be evaluated against the total number of Sesen Bio shares, or, against the total number of tradable Sesen Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sesen Bio's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Sesen Bio shares in existence, roughly 100 shares are currently held short) or 0.0963% of the tradable shares (for every 100,000 tradable Sesen Bio shares, roughly 96 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sesen Bio.

Find out more about how you can short Sesen Bio stock.

Sesen Bio share dividends

We're not expecting Sesen Bio to pay a dividend over the next 12 months.

Sesen Bio share price volatility

Over the last 12 months, Sesen Bio's shares have ranged in value from as little as $0.91 up to $4.8. A popular way to gauge a stock's volatility is its "beta".

SESN.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sesen Bio's is 0.8814. This would suggest that Sesen Bio's shares are less volatile than average (for this exchange).

Sesen Bio overview

Sesen Bio, Inc. , a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. The company's lead product candidates include Vicinium, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC); and VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule (EpCAM)-positive solid tumors. It also develops Vicinium in combination with Durvalumab, which is in Phase I clinical trials for use in the treatment of BCG-unresponsive NMIBC; and Vicinium in combination with AstraZeneca's checkpoint inhibitor for the treatment of squamous cell carcinoma of the head and neck. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc.

Frequently asked questions

What percentage of Sesen Bio is owned by insiders or institutions?
Currently 0.007% of Sesen Bio shares are held by insiders and 24.746% by institutions.
How many people work for Sesen Bio?
Latest data suggests 27 work at Sesen Bio.
When does the fiscal year end for Sesen Bio?
Sesen Bio's fiscal year ends in December.
Where is Sesen Bio based?
Sesen Bio's address is: 245 First Street, Cambridge, MA, United States, 02142
What is Sesen Bio's ISIN number?
Sesen Bio's international securities identification number is: US8177631053
What is Sesen Bio's CUSIP number?
Sesen Bio's Committee on Uniform Securities Identification Procedures number is: 286221106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site